IBDEI0NR ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10692,1,4,0)
;;=4^F64.8
;;^UTILITY(U,$J,358.3,10692,2)
;;=^5003649
;;^UTILITY(U,$J,358.3,10693,0)
;;=F64.9^^42^477^3
;;^UTILITY(U,$J,358.3,10693,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10693,1,3,0)
;;=3^Gender Dysphoria,Unspec
;;^UTILITY(U,$J,358.3,10693,1,4,0)
;;=4^F64.9
;;^UTILITY(U,$J,358.3,10693,2)
;;=^5003650
;;^UTILITY(U,$J,358.3,10694,0)
;;=G21.19^^42^478^10
;;^UTILITY(U,$J,358.3,10694,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10694,1,3,0)
;;=3^Medication-Induced Parkinsonism,Other
;;^UTILITY(U,$J,358.3,10694,1,4,0)
;;=4^G21.19
;;^UTILITY(U,$J,358.3,10694,2)
;;=^5003773
;;^UTILITY(U,$J,358.3,10695,0)
;;=G21.11^^42^478^13
;;^UTILITY(U,$J,358.3,10695,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10695,1,3,0)
;;=3^Neuroleptic-Induced Parkinsonism
;;^UTILITY(U,$J,358.3,10695,1,4,0)
;;=4^G21.11
;;^UTILITY(U,$J,358.3,10695,2)
;;=^5003772
;;^UTILITY(U,$J,358.3,10696,0)
;;=G24.01^^42^478^15
;;^UTILITY(U,$J,358.3,10696,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10696,1,3,0)
;;=3^Tardive Dyskinesia
;;^UTILITY(U,$J,358.3,10696,1,4,0)
;;=4^G24.01
;;^UTILITY(U,$J,358.3,10696,2)
;;=^5003784
;;^UTILITY(U,$J,358.3,10697,0)
;;=G24.09^^42^478^16
;;^UTILITY(U,$J,358.3,10697,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10697,1,3,0)
;;=3^Tardive Dystonia
;;^UTILITY(U,$J,358.3,10697,1,4,0)
;;=4^G24.09
;;^UTILITY(U,$J,358.3,10697,2)
;;=^5003786
;;^UTILITY(U,$J,358.3,10698,0)
;;=G25.1^^42^478^11
;;^UTILITY(U,$J,358.3,10698,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10698,1,3,0)
;;=3^Medication-Induced Postural Tremor
;;^UTILITY(U,$J,358.3,10698,1,4,0)
;;=4^G25.1
;;^UTILITY(U,$J,358.3,10698,2)
;;=^5003792
;;^UTILITY(U,$J,358.3,10699,0)
;;=G25.71^^42^478^14
;;^UTILITY(U,$J,358.3,10699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10699,1,3,0)
;;=3^Tardive Akathisia
;;^UTILITY(U,$J,358.3,10699,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,10699,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,10700,0)
;;=G25.79^^42^478^9
;;^UTILITY(U,$J,358.3,10700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10700,1,3,0)
;;=3^Medication-Induced Movement Disorder,Other
;;^UTILITY(U,$J,358.3,10700,1,4,0)
;;=4^G25.79
;;^UTILITY(U,$J,358.3,10700,2)
;;=^5003800
;;^UTILITY(U,$J,358.3,10701,0)
;;=T43.205A^^42^478^4
;;^UTILITY(U,$J,358.3,10701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10701,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
;;^UTILITY(U,$J,358.3,10701,1,4,0)
;;=4^T43.205A
;;^UTILITY(U,$J,358.3,10701,2)
;;=^5050540
;;^UTILITY(U,$J,358.3,10702,0)
;;=T43.205D^^42^478^5
;;^UTILITY(U,$J,358.3,10702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10702,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
;;^UTILITY(U,$J,358.3,10702,1,4,0)
;;=4^T43.205D
;;^UTILITY(U,$J,358.3,10702,2)
;;=^5050541
;;^UTILITY(U,$J,358.3,10703,0)
;;=T43.205S^^42^478^6
;;^UTILITY(U,$J,358.3,10703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10703,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Sequela
;;^UTILITY(U,$J,358.3,10703,1,4,0)
;;=4^T43.205S
;;^UTILITY(U,$J,358.3,10703,2)
;;=^5050542
;;^UTILITY(U,$J,358.3,10704,0)
;;=G25.71^^42^478^7
;;^UTILITY(U,$J,358.3,10704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10704,1,3,0)
;;=3^Medication-Induced Acute Akathisia
;;^UTILITY(U,$J,358.3,10704,1,4,0)
;;=4^G25.71
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0NR 3748 printed Apr 09, 2024@21:07:41 Page 2
IBDEI0NR ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10692,1,4,0)
+2 ;;=4^F64.8
+3 ;;^UTILITY(U,$J,358.3,10692,2)
+4 ;;=^5003649
+5 ;;^UTILITY(U,$J,358.3,10693,0)
+6 ;;=F64.9^^42^477^3
+7 ;;^UTILITY(U,$J,358.3,10693,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,10693,1,3,0)
+10 ;;=3^Gender Dysphoria,Unspec
+11 ;;^UTILITY(U,$J,358.3,10693,1,4,0)
+12 ;;=4^F64.9
+13 ;;^UTILITY(U,$J,358.3,10693,2)
+14 ;;=^5003650
+15 ;;^UTILITY(U,$J,358.3,10694,0)
+16 ;;=G21.19^^42^478^10
+17 ;;^UTILITY(U,$J,358.3,10694,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,10694,1,3,0)
+20 ;;=3^Medication-Induced Parkinsonism,Other
+21 ;;^UTILITY(U,$J,358.3,10694,1,4,0)
+22 ;;=4^G21.19
+23 ;;^UTILITY(U,$J,358.3,10694,2)
+24 ;;=^5003773
+25 ;;^UTILITY(U,$J,358.3,10695,0)
+26 ;;=G21.11^^42^478^13
+27 ;;^UTILITY(U,$J,358.3,10695,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,10695,1,3,0)
+30 ;;=3^Neuroleptic-Induced Parkinsonism
+31 ;;^UTILITY(U,$J,358.3,10695,1,4,0)
+32 ;;=4^G21.11
+33 ;;^UTILITY(U,$J,358.3,10695,2)
+34 ;;=^5003772
+35 ;;^UTILITY(U,$J,358.3,10696,0)
+36 ;;=G24.01^^42^478^15
+37 ;;^UTILITY(U,$J,358.3,10696,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,10696,1,3,0)
+40 ;;=3^Tardive Dyskinesia
+41 ;;^UTILITY(U,$J,358.3,10696,1,4,0)
+42 ;;=4^G24.01
+43 ;;^UTILITY(U,$J,358.3,10696,2)
+44 ;;=^5003784
+45 ;;^UTILITY(U,$J,358.3,10697,0)
+46 ;;=G24.09^^42^478^16
+47 ;;^UTILITY(U,$J,358.3,10697,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,10697,1,3,0)
+50 ;;=3^Tardive Dystonia
+51 ;;^UTILITY(U,$J,358.3,10697,1,4,0)
+52 ;;=4^G24.09
+53 ;;^UTILITY(U,$J,358.3,10697,2)
+54 ;;=^5003786
+55 ;;^UTILITY(U,$J,358.3,10698,0)
+56 ;;=G25.1^^42^478^11
+57 ;;^UTILITY(U,$J,358.3,10698,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,10698,1,3,0)
+60 ;;=3^Medication-Induced Postural Tremor
+61 ;;^UTILITY(U,$J,358.3,10698,1,4,0)
+62 ;;=4^G25.1
+63 ;;^UTILITY(U,$J,358.3,10698,2)
+64 ;;=^5003792
+65 ;;^UTILITY(U,$J,358.3,10699,0)
+66 ;;=G25.71^^42^478^14
+67 ;;^UTILITY(U,$J,358.3,10699,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,10699,1,3,0)
+70 ;;=3^Tardive Akathisia
+71 ;;^UTILITY(U,$J,358.3,10699,1,4,0)
+72 ;;=4^G25.71
+73 ;;^UTILITY(U,$J,358.3,10699,2)
+74 ;;=^5003799
+75 ;;^UTILITY(U,$J,358.3,10700,0)
+76 ;;=G25.79^^42^478^9
+77 ;;^UTILITY(U,$J,358.3,10700,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,10700,1,3,0)
+80 ;;=3^Medication-Induced Movement Disorder,Other
+81 ;;^UTILITY(U,$J,358.3,10700,1,4,0)
+82 ;;=4^G25.79
+83 ;;^UTILITY(U,$J,358.3,10700,2)
+84 ;;=^5003800
+85 ;;^UTILITY(U,$J,358.3,10701,0)
+86 ;;=T43.205A^^42^478^4
+87 ;;^UTILITY(U,$J,358.3,10701,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,10701,1,3,0)
+90 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
+91 ;;^UTILITY(U,$J,358.3,10701,1,4,0)
+92 ;;=4^T43.205A
+93 ;;^UTILITY(U,$J,358.3,10701,2)
+94 ;;=^5050540
+95 ;;^UTILITY(U,$J,358.3,10702,0)
+96 ;;=T43.205D^^42^478^5
+97 ;;^UTILITY(U,$J,358.3,10702,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,10702,1,3,0)
+100 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
+101 ;;^UTILITY(U,$J,358.3,10702,1,4,0)
+102 ;;=4^T43.205D
+103 ;;^UTILITY(U,$J,358.3,10702,2)
+104 ;;=^5050541
+105 ;;^UTILITY(U,$J,358.3,10703,0)
+106 ;;=T43.205S^^42^478^6
+107 ;;^UTILITY(U,$J,358.3,10703,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,10703,1,3,0)
+110 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
+111 ;;^UTILITY(U,$J,358.3,10703,1,4,0)
+112 ;;=4^T43.205S
+113 ;;^UTILITY(U,$J,358.3,10703,2)
+114 ;;=^5050542
+115 ;;^UTILITY(U,$J,358.3,10704,0)
+116 ;;=G25.71^^42^478^7
+117 ;;^UTILITY(U,$J,358.3,10704,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,10704,1,3,0)
+120 ;;=3^Medication-Induced Acute Akathisia
+121 ;;^UTILITY(U,$J,358.3,10704,1,4,0)
+122 ;;=4^G25.71
